Carlsbad, CA, United States of America

Marek Liyanage



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **The Innovations of Marek Liyanage: A Pioneer in Proteomic Analysis**

Introduction

Marek Liyanage, an esteemed inventor based in Carlsbad, California, has made significant contributions to the field of proteomic analysis through his innovative work. His expertise in the realm of biochemistry has led to the development of patentable inventions that enhance the scientific community's ability to analyze complex protein mixtures.

Latest Patents

Liyanage holds a notable patent titled "Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis." This invention introduces tagged acyl phosphate probes, also known as TAPPs, and outlines the methods for their preparation and application. The patented technology aims to simplify and increase the accuracy of identifying changes in the presence, quantity, or activity of target proteins, particularly nucleotide-binding proteins. The profiling methodologies developed in this patent are instrumental for researchers working with complex protein mixtures.

Career Highlights

Currently, Marek Liyanage is affiliated with Activx Biosciences, Inc., where he applies his vast knowledge and skills in the biochemistry sector. His work concentrates on refining techniques that facilitate the study of proteins, contributing to advances in drug discovery and disease research.

Collaborations

Throughout his career, Liyanage has collaborated with other notable professionals in the field, including David Alan Campbell and Anna Katrin Szardenings. These partnerships have fostered a creative environment for innovation, enabling them to push the boundaries of proteomic research.

Conclusion

Marek Liyanage's contributions to the field of proteomics through his patented invention reflect a commitment to advancing scientific knowledge and methodologies. His work at Activx Biosciences, Inc. and collaborations with fellow researchers highlight his important role in the ongoing quest to understand complex protein interactions better.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…